Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1.*
And upon getting a prescription, patients can easily communicate with their provider, and Ro.Cos care team all through Ro.Cos apps
In addition the market for weight loss drugs was considered too small to be commercially viable (Gilbert, Rosenthal, Jan 2024
Side effects: Similarities and potential differences Weight loss patches currently available are not GLP-1 mimetics, and may not have the same side effects as GLP-1 drugs, like Wegovy, Ozempic, Mounjaro, or Zepbound
Clinical implication Although the association between GLP-1 RAs and gallbladder/biliary diseases has been supported by multiple studies, causality has not been definitively established
doi: 10.3389/fimmu.2022.1089987 137 ZouJReddivariLShiZLiSWangYBretinAet al